Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of intravenous flecainide plus oral ranolazine for recent-onset atrial fibrillation
2021-004865-11Phase 3Active
- Sponsor
- Win Medica
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of flecainide and ranolazine in Atrial fibrillation (AFib), sponsored by Win Medica. Started Mar 2022; status: active.
02
Drugs
flecainideranolazine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2021-004865-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004865-11.